Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cystic pancreatic tumors]

C Schneider1, T Reck, K R Greskötter

  • 1Chirurgische Klinik mit Poliklinik, Universität Erlangen-Nürnberg.

Langenbecks Archiv Fur Chirurgie
|January 1, 1993
PubMed
Summary

Pancreatic cystic tumors, including serous cystic adenomas and mucinous cystadenocarcinomas, require accurate diagnosis. Surgical resection offers a potential cure, but outcomes vary by tumor type and stage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The growth suppressing gas1 product is a GPI-linked protein.

FEBS letters·2000
Same author

Analysis of the domain requirement in Gas1 growth suppressing activity.

FEBS letters·2000
Same author

Proof of genetic heterogeneity in the proximal myotonic myopathy syndrome (PROMM) and its relationship to myotonic dystrophy type 2 (DM2).

Neuromuscular disorders : NMD·2000
Same author

Hyperparathyroidism in a patient with proximal myotonic myopathy (PROMM).

Neuromuscular disorders : NMD·2000
Same author

Large vasodilatations in skeletal muscle of resting conscious dogs and their contribution to blood pressure variability.

The Journal of physiology·2000
Same author

Cell-cycle regulation of the p53-inducible gene B99.

FEBS letters·2000

Area of Science:

  • Gastroenterology
  • Surgical Oncology
  • Pathology

Context:

  • Historically, pancreatic cystic tumors were broadly classified as adenomas or cystadenocarcinomas.
  • Recent advancements allow differentiation into serous cystic adenoma, mucinous cystadenoma, papillary cystic tumor, and mucinous cystadenocarcinoma.
  • Imaging modalities like CT, sonography, and ERCP aid in pseudocyst identification but struggle with precise tumor differentiation.

Purpose:

  • To review the classification and clinical outcomes of various pancreatic cystic tumors.
  • To evaluate the resectability and recurrence rates of different cystic tumor subtypes.
  • To assess the long-term prognosis for patients with resected pancreatic cystic neoplasms.

Summary:

  • The study analyzed ten serous cystic adenomas, nine cystadenocarcinomas, and four malignant papillary-cystic tumors between 1979 and 1990.
  • Curative resections were achieved in most serous cystic adenomas, all papillary-cystic tumors, and some mucinous cystadenomas and cystadenocarcinomas.
  • Recurrence-free survival was observed in patients with resected adenomas, while cystadenocarcinomas showed variable postoperative outcomes.

Impact:

  • Highlights the importance of precise pathological classification for predicting pancreatic cystic tumor behavior.
  • Demonstrates the potential for curative surgical management of specific cystic pancreatic neoplasms.
  • Provides insights into the long-term prognosis and challenges associated with malignant cystic pancreatic tumors.

Related Experiment Videos